Select Medical to Go Private in $2.05 Billion All-Cash Acquisition at $16.50 Per Share

summarizeSummary

Select Medical Holdings Corp. is being acquired and taken private for $16.50 per share in an all-cash transaction valued at $2.05 billion, leading to its delisting from the NYSE.

check_boxKey Events

• Definitive Take-Private Agreement

  The company entered into a merger agreement on March 2, 2026, to be acquired by a consortium including WCAS and executive officers.

• All-Cash Consideration

  Public shareholders will receive $16.50 per share in cash, a 21% premium to the unaffected share price of $13.65 on November 21, 2025.

• Significant Transaction Value

  The acquisition is valued at approximately $2.05 billion, representing a complete acquisition of the company.

• Delisting and Deregistration

  Upon completion, the company will become privately held, delisted from the NYSE, and deregistered, ending its public trading status.

auto_awesomeAnalysis

This SC 13E3 filing provides the comprehensive transaction statement for the definitive agreement under which Select Medical Holdings Corp. will be acquired and taken private by a consortium led by WCAS and certain executive officers. The transaction, valued at approximately $2.05 billion, offers public shareholders $16.50 per share in cash, representing a 21% premium to the unaffected share price of $13.65 on November 21, 2025. The company will be delisted from the NYSE and deregistered, marking a fundamental change for public investors. The deal is supported by a unanimous recommendation from a Special Committee of independent directors and requires approval from both a majority of outstanding shares and unaffiliated stockholders.